Caren Deardorf - Insider Trading & Ownership

Location
C/O Magenta Therapeutics, Inc., 100 Technology Square, Cambridge, MA
Summary
The estimated net worth of Caren Deardorf is at least $780K dollars as of June 13, 2025. Caren Deardorf is the Director of Crinetics Pharmaceuticals, Inc. and owns shares of Crinetics Pharmaceuticals, Inc. (CRNX) stock worth about $543K. Caren Deardorf is the Chief Commercial Officer of Magenta Therapeutics, Inc. and owns shares of Dianthus Therapeutics, Inc. /DE/ (DNTH) stock worth about $237K.
Signature
/s/ Tobin Schilke, as attorney-in-fact
All Insider Reports
All Insider Reports

Ownership of Caren Deardorf

Symbol Company Relationship Holdings Value Past Year Net Change Change % Report Period
CRNX Crinetics Pharmaceuticals, Inc. Director $543K Jun 11, 2025
DNTH Dianthus Therapeutics, Inc. /DE/ Chief Commercial Officer $237K Nov 30, 2022

Insider Transactions Reported by Caren Deardorf:

Sym Company Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.